Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an…
- Introduced Feb 27, 2025
- In committee Mar 4, 2025
- Died
- Passed the Senate
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
The Act allows doctors to give some patients novel types of treatment. (Flesch Readability Score: 74.8). Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration. Provides protections, including a waiver of liability, for health care practitioners, health care facilities, professional organizations or associations and manufacturers or distributors of investigational products that comply with the Act.
Read the full official title (38 words)
Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration.
Every action
4 steps, oldest first, as the legislature records them.
- HouseFirst reading. Referred to Speaker's desk.
- CommitteeReferred to Behavioral Health and Health Care. · House Behavioral Health and Health Care
- CommitteePublic Hearing held. · House Behavioral Health and Health Care
- HouseIn committee upon adjournment.
Roll calls
No recorded votes on this bill yet.
Sponsors
The member who introduced it, joined by 1 cosponsor: 1 Republican.
- BB Ben BowmanD Primary sponsor · District 25
All 1 cosponsor
From Oregon's official records (api.oregonlegislature.gov), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.